ECFSPR Scientific Committee: Andreas Pfleger, Department of Paediatrics and Adolescent Medicine, Division of Paediatric Pulmonology and Allergology, Medical University of Graz, Graz, Austria; Géraldin Daneau, Sciensano, Epidemiology and Public Health, Health Services Research, Brussels, Belgium; Elise Lammertijn, Cystic Fibrosis Europe and Association Muco ASBL – Mucovereniging VZW, Brussels, Belgium; Milan Macek, Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic; Pavel Drevinek, Department of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic; Hanne Vebert Olesen, Department of Paediatrics and Adolescent Medicine, Cystic Fibrosis Centre, Aarhus University Hospital, Aarhus, Denmark; Pierre-Régis Burgel, Respiratory Medicine and National Cystic Fibrosis Reference Center, Cochin Hospital, AP-HP, Université de Paris, Institut Cochin, INSERM U1016, Paris, France; Lydie Lemonnier-Videau, Vaincre la Mucoviscidose, Paris, France; Lutz Naehrlich, Universities of Giessen and Marburg Lung Centre, German Centre for Lung Research, Justus Liebig University Giessen, Giessen, Germany; Andrea Párniczky, Heim Pál National Paediatric Institute, Budapest and Institute for Translational Medicine, University of Pécs, Medical School, Pécs, Hungary; Godfrey Fletcher, The Cystic Fibrosis Registry of Ireland, Dublin, Ireland; Meir Mei-Zahav, Pulmonary Institute, Schneider Children's Medical Centre of Israel, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Rita Padoan, Cystic Fibrosis Regional Support Centre, Department of Paediatrics, University of Brescia, Brescia and Scientific Board of Italian CF Registry, Rome, Italy; Anna Zolin, Department of Clinical Sciences and Community Health, Laboratory of Medical Statistics, Biometry and Epidemiology “G.A. Maccaccaro”, University of Milan, Milan, Italy; Elina Aleksejeva, Department of Pneumology, Children's Clinical University Hospital, Riga Stradinš University, Riga, Latvia; Kestutis Malakauskas, Adult Cystic Fibrosis Centre, Department of Pulmonology, Lithuanian University of Health Sciences, Kaunas, Lithuania; Oxana Turcu, Department of Paediatrics, Ambulatory Cystic Fibrosis and Other Rare Diseases Centre, Institute for Maternal and Child Healthcare, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Republic of Moldova; Domenique Zomer, Dutch Cystic Fibrosis Foundation (NCFS), Baarn, The Netherlands; Stojka Fustik, Centre for Cystic Fibrosis, University Children's Hospital, Skopje, North Macedonia; Ivana Arnaudova Danevskai, Centre for Cystic Fibrosis, Children and Adults, Institute for Respiratory Diseases in Children, Kozle, North Macedonia; Luísa Pereira, Centre for Cystic Fibrosis, Hospital de Santa Maria, Lisbon, Portugal; Liviu Pop, Victor Babes University of Medicine and Pharmacy Timisoara, National Cystic Fibrosis Centre, Timisoara, Romania; Elen Kondratyeva, Research Centre for Medical Genetics, Moscow, Russian Federation; Milan Rodić, National Centre for Cystic Fibrosis, Mother and Child Health Institute of Serbia “Dr Vukan Čupić”, Belgrade, Serbia; Hana Kayserová, Cystic Fibrosis Centre, University Hospital of Bratislava, Bratislava, Slovakia; Uroš Krivec, Department of Paediatric Pulmonology, University Children's Hospital, Ljubljana University Medical Centre, Ljubljana, Slovenia; Maria Dolores Pastor-Vivero, Paediatric Pneumology and Cystic Fibrosis Unit, Osakidetza, Hospital Universitario Cruces, Bizkaia, Spain; Christina Krantz, Uppsala CF Centre, Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden; Anders Lindblad, Gothenburg CF Centre, Queen Silvia Children's Hospital, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Andreas Jung, Paediatric Pulmonology, University Children's Hospital Zurich, Zurich, Switzerland; Halyna Makukh, Institute of Hereditary Pathology, Ukrainian National Academy of Medical Sciences, Lviv, Ukraine; Siobhán B. Carr, Department of Respiratory Paediatrics, Royal Brompton Hospital and NHLI, Imperial College, London, UK; Sarah Clarke, Cystic Fibrosis Trust, London, UK.